Skip to content
★ Sign in to follow
HD

Heather D. Turner

Executive
Atara Biotherapeutics, Inc.Sangamo Therapeutics, IncOrexigen Therapeutics, Inc.
Total declarations
23
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€2.4M

Latest filing published 27 Feb 2019 for Sangamo Therapeutics, INC.

Filing timeline

BuySale
Heather D. Turner

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

Heather D. Turner: trading record in brief

Filings by Heather D. Turner span 3 companies, the busiest being Atara Biotherapeutics, Inc., Orexigen Therapeutics, Inc. and Sangamo Therapeutics, Inc. Between 17 July 2012 and 25 February 2019, the trades on record add up to 23 filings.

No open-market purchase appears, only 13 sales worth €2.4M. Outside the open market, there are 5 share grants and 5 option exercises.

The newest entry dates from 27 February 2019: a share grant, in Sangamo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Heather D. Turner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total

22 of 22 declarations